NCT Number: NCT00455338
Effect of Meal Composition on Postprandial Testosterone Concentration in Women With Polycystic Ovary Syndrome
The primary objective is to determine if meals of different fat and fiber content affect postprandial plasma testosterone concentration in women with polycystic ovary syndrome. Our hypothesis is that a high-fiber meal will have a greater reduction in testosterone composition compared with a high-fat meal.
Looking for future studies?
Notify MeKey information
Conditions
Age range
19 year–40 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
About this study
The study participants are 15 women with PCOS between the ages of 19-40. All participants must be in good health, non-smokers, and not pregnant or lactating. For three days prior to both study visits, participants follow a standard 2,000 calorie meal plan of approximately 30% fat, 55% carbohydrate and 15% protein. On the morning of the two study visits, participants arrive at the General Clinical Research Center at 0700 h. A venicatheter is inserted into an antecubital vein for collection of blood samples and the catheter is kept open with saline. A baseline blood sample is taken for measurement of estradiol, progesterone, glucose, insulin, testosterone, and sex hormone binding globulin (SHBG). Participants are then served the test meal and asked to consume it within 15 minutes. The high-fat, low-fiber and low-fat, high-fiber meals are isocaloric and are 62% and 6% fat, 24% and 81% carbohydrate, and have 1g and 26.8g of fiber, respectively. After each meal, a blood sample is taken at 30 minutes and every hour for six hours for measurement of testosterone, SHBG, glucose and insulin. During this time participants remain comfortably seated or reclined. After the last blood draw, the catheter was removed and participants are given a complementary meal.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Chronic oligo/anovulation - intermenstrual periods of ≥ 45 days or ≤ 8 menses per year.
- Hyperandrogenemia - elevated total testosterone or free androgen index (ratio of testosterone/SHBG x 100). To participate in the study, women must have total testosterone >50 ng/dL or a free androgen index >1.5
- In good general health
Exclusion criteria
- Currently pregnant or lactating
- Use of confounding medications such as oral contraceptives or other hormonal medication, lipid lowering medications or insulin sensitizing agents such as metformin or the glitazones.
- Tobacco use
- Alcohol consumption of more than two drinks per day
- Unusual meal patterns (including no breakfast, breakfast before 6 am or breakfast after 10am.
- Untreated hyperprolactinaemia (Prolactin >25ng/ml)
- Uncontrolled hypothyroidism
- History of blood clotting disorder
- Diagnosis of anemia at baseline visit
- Presence or history of diabetes mellitus
- Existence of an organic intra cranial lesion such as a pituitary tumor.
- Presence or history of coronary artery disease
Treatment and study plan
Primary outcomes
-
Testosterone
Secondary outcomes
-
SHBG
-
Glucose
-
Insulin
Interested in participating?
Looking for future studies?
Notify MeSponsors and collaborators
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Nih
Registry information
Official study title
The Effect of Meals of Varying Fat and Fiber Content on Postprandial Testosterone Concentration in Women With Polycystic Ovary Syndrome
Important dates
- Study start
- 2005
- Study completion
- 2006
- First posted
- Apr 3, 2007
- Registry last updated
- Apr 3, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficacy of Mazdutide for Treating PCOS
NCT06519656
Adnexal Diseases, Cysts
Shanghai, China
View Trial DetailsBody Fat as Determinant of Female Gonadal Dysfunction
NCT03841981
46, XX Disorders of Sex Development, Adnexal Diseases
Madrid, Spain
View Trial DetailsEffect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females
NCT06418347
Adnexal Diseases, Cysts
Cairo, Cairo Governorate, Egypt
View Trial DetailsThe Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
NCT03049462
Adnexal Diseases, Body Weight
Bethesda, Maryland, United States
View Trial Details